Page last updated: 2024-11-07
cellobionolactone
Description
Cellobionolactone is a cyclic derivative of cellobiose, a disaccharide composed of two glucose units linked by a β-(1→4) glycosidic bond. It is a promising candidate for various applications, including:
- **Synthesis:** Cellobionolactone can be synthesized via various methods, including enzymatic hydrolysis of cellulose or chemical oxidation of cellobiose.
- **Effects:** Cellobionolactone has been shown to possess various biological activities, including antibacterial, antifungal, and antioxidant properties.
- **Importance:** It is a renewable and sustainable resource derived from cellulose, a major component of plant biomass.
- **Study:** Research on cellobionolactone focuses on exploring its potential as a precursor for various applications, including bio-based materials, pharmaceuticals, and food additives.
- **Other Applications:** Cellobionolactone has also been investigated as a building block for the synthesis of novel polymers, such as biodegradable plastics and hydrogels.'
cellobionolactone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
cellobiono-1,5-lactone : A disaccharide consisting of D-glucono-1,5-lactone having a beta-D-glucosyl residue at the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (15)
Synonym |
beta-d-glucopyranosyl-(1->4)-d-glucono-1,5-lactone |
CHEBI:17863 |
52762-22-8 |
cellobionolactone |
C01093 |
cellobiose-1,5-lactone |
cellobiono-1,5-lactone |
CHEBI:136504 |
(3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-one |
nsc 196590 |
4-o-beta-d-glucopyranosyl-d-gluconic acid delta-lactone |
d-gluconic acid, 4-o-beta-d-glucopyranosyl-, delta-lactone |
FSICMNGKCHFHGP-ZNLUKOTNSA-N |
Q27102668 |
DTXSID001316284 |
Drug Classes (1)
Class | Description |
disaccharide | A compound in which two monosaccharides are joined by a glycosidic bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.58
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.58 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.37 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |